[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-334370-105":59,"doc-detail-334370-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","the-protective-role-of-anti-parkinsonian-drugs-in-pancreatic-cancer-risk-a-comprehensive-case-control-study-in-taiwan","The protective role of anti-parkinsonian drugs in pancreatic cancer risk - A comprehensive case-control study in Taiwan","","Pancreatic cancer remains among the most lethal cancers, and outcomes are poor despite recent therapeutic advances. A population-based case-control study in Taiwan linked Health and Welfare Data Science Center records with the Taiwan Cancer Registry to evaluate whether anti-parkinsonian drugs are associated with pancreatic cancer risk. The analysis included 18,921 cases and 75,684 matched controls, using conditional logistic regression. Significant risk reductions were observed for administration of specific anti-parkinsonian medications, including anticholinergic agents, tertiary amines, dopa derivatives, and dopamine receptor agonists, reported as adjusted odds ratios with confidence intervals. Age-stratified results showed varying efficacy by age group.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/the-protective-role-of-anti-parkinsonian-drugs-in-pancreatic-cancer-risk-a-comprehensive-case-control-study-in-taiwan/334370/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/the-protective-role-of-anti-parkinsonian-drugs-in-pancreatic-cancer-risk-a-comprehensive-case-control-study-in-taiwan/334370.png","ImageObject",300,407,{"name":92,"@type":93},"Valentina","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-24","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the purpose of the study on anti-parkinsonian drugs and pancreatic cancer?","Question",{"text":112,"@type":113},"To identify the association of anti-parkinsonian drugs with pancreatic cancer risk across different age groups using a Taiwan population-based case-control design.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was pancreatic cancer risk analyzed in the study?",{"text":117,"@type":113},"The study used conditional logistic regression to assess the impact of anti-parkinsonian drugs on pancreatic cancer risk, reporting adjusted odds ratios and 95% confidence intervals.",{"name":119,"@type":110,"acceptedAnswer":120},"Which anti-parkinsonian medication classes were linked to reduced pancreatic cancer risk?",{"text":121,"@type":113},"Statistically significant associations were found for anticholinergic agents, tertiary amines, dopa derivatives, and dopamine receptor agonists, indicating reduced risk.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},334370,1790401201,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":44,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":4},13056703020460,"https://ap-avatar.wpscdn.com/avatar/be000253dac470eee5d?_k=1778207105932848923","Received: 9 September 2024  \nRevised: 1 November 2024  \nAccepted: 20 November 2024  \n\n| DOI: 10. 1111/cas.16422 |  |\n| --- | --- |\n| OR I G I NAL ART I C L E\u003Cbr>| |\n| The protective role of anti-parkinsonian drugs in pancreatic cancer risk: A comprehensive case–control study in Taiwan\u003Cbr>Hsuan-Chia Yang1,2,3,4 | Wen-Chi Chou5 | Phung-Anh Nguyen3,6,7,8 | Nhi Thi Hong Nguyen9,10 | Nguyen Thi Phuong1 | Ching-Huan Wang11 | Jason C. Hsu3,7,8,12  | Ming-Chin Lin1,13,14 | Chih-Wei Huang1,2,3 \u003Cbr>1Graduate Institute of Biomedical Informatics, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan\u003Cbr>2International Center for Health Information Technology (ICHIT), College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan 3Clinical Big Data Research Center, Taipei Medical University Hospital, Taipei Medical University, Taipei, Taiwan\u003Cbr>4Research Center of Big Data and Meta-Analysis, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan\u003Cbr>5Department of Hematology and Oncology, Chang Gung Memorial Hospital at Linkou and College of Medicine, Chang Gung University, Taoyuan, Taiwan 6Graduate Institute of Data Science, College of Management, Taipei Medical University, Taipei, Taiwan\u003Cbr>7Clinical Data Center, Office of Data Science, Taipei Medical University, Taipei, Taiwan\u003Cbr>8 Research Center of Health Care Industry Data Science, College of Management, Taipei Medical University, Taipei, Taiwan\u003Cbr>9School of Nutrition and Health Sciences, Taipei Medical University, Taipei, Taiwan\u003Cbr>10 Health Personnel Training Institute, University of Medicine and Pharmacy, Hue University, Hue, Vietnam\u003Cbr>11Biomedical Informatics and Data Science (BIDS) Section, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA\u003Cbr>12International Ph. D. Program in Biotech and Healthcare Management, College of Management, Taipei Medical University, Taipei, Taiwan 13 Department of Neurosurgery, Wang-Fang Hospital, Taipei Medical University, Taipei, Taiwan\u003Cbr>14Taipei Neuroscience Institute, Taipei Medical University, Taipei, Taiwan |  |\n| Correspondence\u003Cbr>Chih-Wei Huang, International Center for Health Information Technology, College of Medical Science and Technology, Taipei Medical University, 11F. , No. 301, Yuantong Road, Zhonghe District, Taipei 235, Taiwan. [Email:](Email: gracehuang@tmu.edu.tw)[ gracehuang@tmu.edu.tw](Email: gracehuang@tmu.edu.tw) | \u003Cbr>Abstract\u003Cbr>Pancreatic cancer is among the deadliest cancers, with a grim prognosis despite advances in treatment. We conducted a population-based case–control study from Taiwan, linking Health and Welfare Data Science Center data to the Taiwan Cancer Registry, which offers a promising strategy for its treatment through drug repurposing. The study aims to identify the association of anti-parkinsonian drugs with pancreatic cancer risk across different age groups. The analysis encompassed 18,921 pancreatic cancer cases and 75,684 matched controls, employing conditional logistic regression to assess the impact of anti-parkinsonian drugs on the risk of pancreatic cancer. Key findings revealed a statistically significant association of the administration with specific anti-parkinsonian medications, including anticholinergic agents, tertiary amines, dopa derivatives, and dopamine receptor agonists, with a reduction in pancreatic cancer risk. These associations were represented as adjusted odds ratios (aORs), ranging from 0.620 (95% CI 0.470–0. 810) to 0.764 (95% CI 0.655–0. 891) . |\n| Abbreviations: aOR, adjusted odds ratio; CCI, Charlson comorbidity index; CI, confidence interval; HWDC, Health and Welfare Data Science; IDO1, indoleamine-2,3-dioxygenase; MOHW, Ministry of Health and Welfare; PDAC, pancreatic ductal adenocarcinoma. |  |\n\nThis is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properl","cbCaig9PVfErl53k","https://ap.wps.com/l/cbCaig9PVfErl53k","pdf",800993,"English","# Abstract\n## Study design and data sources\n## Statistical analysis and outcomes\n## Age-stratified findings\n# Keywords\n# Introduction","[{\"question\":\"What was the purpose of the study on anti-parkinsonian drugs and pancreatic cancer?\",\"answer\":\"To identify the association of anti-parkinsonian drugs with pancreatic cancer risk across different age groups using a Taiwan population-based case-control design.\"},{\"question\":\"How was pancreatic cancer risk analyzed in the study?\",\"answer\":\"The study used conditional logistic regression to assess the impact of anti-parkinsonian drugs on pancreatic cancer risk, reporting adjusted odds ratios and 95% confidence intervals.\"},{\"question\":\"Which anti-parkinsonian medication classes were linked to reduced pancreatic cancer risk?\",\"answer\":\"Statistically significant associations were found for anticholinergic agents, tertiary amines, dopa derivatives, and dopamine receptor agonists, indicating reduced risk.\"}]","The protective role of anti-parkinsonian drugs in pancreatic cancer risk - A comprehensive case-control study in Taiwan | PDF",1790006399,23]